OBJECTIVES: Midline unifocalization has been developed for the surgical treatment of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. All patients will eventually require reoperation because of the presence of a conduit, and some patients may also require revision of the distal unifocalized bed. The purpose of this study was to analyse the need for unifocalization revision following midline unifocalization.
INTRODUCTION
The midline unifocalization approach was developed by Hanley and colleagues [1] for the surgical treatment of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries (PA/VSD/MAPCAs) [1] . This approach is quite versatile and can be utilized for the wide heterogeneity of MAPCAs and pulmonary artery anatomy [2] [3] [4] [5] [6] . We recently summarized an experience with 307 patients undergoing primary surgical treatment in which 93% of the patients ultimately achieved complete repair [7] . The mean right ventricle to aortic (RV/Ao) peak systolic pressure ratio was 0.36 ± 0.08. These data demonstrate that the majority of the patients with PA/VSD/MAPCAs can achieve complete repair with low right ventricular pressures.
The long-term fate of unifocalized MAPCAs has been the subject of much speculation. We have previously shown that most patients undergoing complete repair of PA/VSD/MAPCAs have little change in RV/Ao pressure ratios over time [8] , as documented by a comparison of these values in the same patient at the initial repair (0.39 ± 0.07) and after conduit replacement (0.36 ± 0.7). This cohort of 80 patients was a select subgroup of patients as they had achieved complete repair status and had also survived the complete repair procedure, the interim period and the conduit change. The inference from these data was that the reconstructed MAPCA bed maintained growth commensurate with the visceral growth of the body.
Skeptics of the unifocalization approach have pointed out that MAPCAs are neither embryologically nor anatomically normal pulmonary artery vessels [9] . These authors have raised concerns over the long-term viability of unifocalized MAPCAs [10, 11] .
Although there is no doubt that MAPCAs differ widely from pulmonary arteries, there is also no evidence to suggest that unifocalized MAPCAs will behave any better or worse than pulmonary arteries with abnormal architecture that require extensive surgical reconstruction. There is the additional confounding factor that approximately 20% of patients with MAPCAs do not have any central pulmonary arteries [2, 6, 7] , meaning that the MAPCAs are the sole source of pulmonary blood flow, regardless of any theoretical preferences or concerns. Currently, there are insufficient data to assess the long-term performance of unifocalized MAPCAs.
Over the past 20 years, there have been many articles published on the subject of the surgical treatment of PA/VSD/ MAPCAs. These have included the overall results of different surgical strategies and assessments of the risk factors for surgery [12] [13] [14] . However, to date, there has not been an article that has focused on patients who have undergone unifocalization and subsequently required a unifocalization revision. The purpose of this article was to analyse the risk factors associated with the need for unifocalization revision.
MATERIALS AND METHODS
This was a retrospective review of patients who had the diagnosis of PA/VSD/MAPCAs and who underwent a primary midline unifocalization at Stanford University. The study was approved by the Institutional Review Board of Stanford University (Protocol ID 33924). There were 241 patients (116 males and 125 females) who met these criteria during the time period from 2001 to February 2017. Eighty-five (34%) patients had DiGeorge syndrome (22q11 deletion), and 7 (3%) patients had Alagille syndrome. The median age at the time of midline unifocalization was 4.5 months (range from 2 weeks to 11 years).
Specifically excluded from this analysis were 66 patients who underwent their primary surgical procedure at Stanford University during this same time frame but were assigned to a procedure other than midline unifocalization. This included 46 patients who had dual-supply MAPCAs and underwent an initial aortopulmonary window (Mee shunt) and 20 patients who underwent other palliative procedures (15 had a ductus or hemitruncus to one lung and MAPCAs to the contralateral lung). These patients were excluded from the current analysis because the majority of aortopulmonary window patients never had a unifocalization of MAPCAs and the ductus/hemitruncus patients had a unifocalization of only one lung. In addition, we have excluded several hundred patients from this analysis who underwent a surgical procedure at an outside institution prior to referral to Stanford University. These patients often had procedures that were not entirely successful and resulted in the loss of pulmonary blood flow to a variable number of lung segments and require rehabilitative procedures that are far different in scope and prognosis.
The patients had a mean of 4.0 ± 1.2 MAPCAs. This included 2.2 ± 1.0 MAPCAs to the right lung (with a range of 1-5) and 1.8 ± 0.8 MAPCAs to the left lung (with a range of 1-4). Sixty-five patients had absent central pulmonary arteries, including 45 with predominantly single-supply MAPCAs and 20 with either a ductus arteriosus or a hemitruncus to one lung and MAPCAs to the contralateral lung.
Of the 241 patients, 204 (85%) patients underwent a singlestage complete repair, including complete closure of the VSD and placement of an aortic valved conduit from the right ventricle to the reconstructed pulmonary bed. A transthoracic pressure line was placed in all patients who underwent a complete repair, and the right ventricle to aortic pressure ratios were recorded at the conclusion of that operation. The mean right ventricle to aorta peak systolic pressure ratio for these 204 patients was 0.36 ± 0.09. Thirty-seven (15%) patients underwent a unifocalization and placement of a central shunt from the ascending aorta to the reconstructed pulmonary bed. The mean right ventricle to aorta peak systolic pressure for the 24 patients who subsequently underwent complete repair was 0.42 ± 0.07. A flow chart for these 241 patients is shown in Fig. 1 .
The suitability for single-stage complete repair can be assessed based on the preoperative systemic oxygen saturation, which provides a good indicator of the overall pulmonary blood flow. Patients with saturations of 85% will have a Q p :Q s between 1.5 and 2.0 and thus will have a well-developed pulmonary vascular bed. These patients can almost invariably undergo a single-stage complete repair, and we no longer perform a flow study in this setting. Patients with saturations around 80% will have a Q p :Q s of 1.0, and we would perform a flow study in this circumstance to determine the suitability for single-stage complete repair. Patients with saturations of 75% or less will have a Q p :Q s substantially below 1.0, and some may not be suitable candidates for a single-stage complete repair. Many of the patients who are unable to undergo a single-stage complete repair can subsequently achieve complete repair status.
For the purpose of this article, 'operative' mortality refers to deaths following the index (initial) operation for each patient, 'interim' mortality refers to deaths that occurred prior to complete repair and 'late' mortality refers to deaths following complete repair. There were 3 operative deaths in the single-stage complete repair subgroup and 3 in the unifocalization/shunt cohort. Thus, there were 235 (97%) survivors of the initial surgical procedures. There were an additional 8 late deaths after single-stage complete repair and 5 interim deaths after the unifocalization/shunt. The actuarial curve for these 2 cohorts is shown in Fig. 2 . The survivors have been followed up for a median of 4.5 years.
Seventy-eight patients have subsequently undergone a reoperation at Stanford University. This includes 52 patients who underwent a single-stage complete repair and 26 patients who underwent a unifocalization and shunt (Fig. 3) . For the 52 patients who had a previous complete repair, the subsequent operations were conduit changes in 16 patients, conduit changes and revisions within the hilum in 6 patients and conduit changes and revisions beyond the hilum of the unifocalized bed in 30 patients. The decision to undertake unifocalization revision was based on a combination of pressure drops across the segments of the pulmonary arteries, angiographic appearance and the quality of the distal vessels supplied by this segment. For the 26 patients who underwent a unifocalization and shunt, the subsequent operations were complete repair with conduit placement in 11 patients, complete repair with conduit placement in conjunction with surgical revision confined to within the hilum in 1 patient and revision of the distal unifocalized bed beyond the hilum with (n = 12) or without (n = 2) concomitant complete repair in 14 patients. There was 1 (1.4%) operative death which occurred following the reoperative procedure.
The 44 patients who required revisions of the unifocalized bed beyond the hilum are the specific focus of the remainder of this study. These 44 patients will be compared with the 191 operative survivors of midline unifocalization who have not required unifocalization revision. The 30 patients who had undergone a complete repair at their initial operation had a mean pulmonary artery to aortic pressure ratio of 0.82 ± 0.18 (range 0.36-1.41). This represents a mean increase of 0.38 ± 0.08 compared with the values measured in the operating room at the time of the initial repair. The median number of affected lung segments for all 44 patients was 9 (range 4-18). The median interval between initial unifocalization and revision was 12 months compared with 31 months for the 34 patients who have undergone reoperations but did not require unifocalization revision (Fig. 4) .
The surgical technique that we have developed for unifocalization revision is performed through a midline sternotomy. The conduit and unifocalized pulmonary artery bed are dissected as much as is feasible prior to institution of bypass. This dissection is performed circumferentially down to the level of the ostia of the basilar segments, taking care to push the lung tissue away from segmental origins. A typical case is shown in Fig. 5A , demonstrating long-segment stenoses to both the right and left lower lobes and conduit dysfunction. After instituting a bypass, the patient is cooled to 25 C. The conduit is removed, and the right and left branch pulmonary arteries are divided (Fig. 5B) . The lobar and segmental branches are controlled with vascular clips. The individual branch pulmonary arteries are then incised along the inferior and medial border to the lower lobe segmental vessels (Fig. 5C ). pulmonary artery homograft is then used to patch augment the pulmonary artery (Fig. 5D ). The branch pulmonary arteries are subsequently brought together, and a new aortic homograft is placed from the right ventricle to the reconstructed pulmonary arteries (Fig. 5E ). All these procedures are performed on a beating heart with full flow for 25 (i.e. 100 ml/kg/min), with the exception of patients who were undergoing concomitant VSD repair, in which circumstance the aorta is cross-clamped and the heart arrested during this phase of the operation.
The results are reported as means ± standard errors, and medians and ranges where appropriate. Statistical analysis to compare the groups was performed using the Pearson's v 2 test or the Fisher's exact test. Comparison of actuarial curves was performed using the Cox regression analysis.
RESULTS
An analysis of the risk factors for requiring unifocalization revision was performed by comparing the 44 patients who required unifocalization revision to the 191 patients who did not require revision. This analysis revealed 3 factors that were significantly different between these 2 subgroups. First, patients who underwent a unifocalization/shunt had a higher prevalence of requiring unifocalization revision than patients who had a single-stage complete repair (37.8% vs 14.7%, P < 0.001, Fig. 6A ). Second, patients who required a unifocalization revision had a higher RV/ Ao pressure at the conclusion of the complete repair compared with patients who did not need unifocalization revision (0.44 ± 0.08 vs 0.33 ± 0.07, P < 0.001, Fig. 6B ). Finally, patients who had absent central pulmonary arteries had a higher prevalence of requiring unifocalization revision than patients with central pulmonary arteries (32.8% vs 13.4%, P < 0.001, Fig. 6C ).
There were numerous factors that we compared between the 44 patients who required unifocalization revision and the 191 who did not require revision that did not achieve statistical significance (see Table 1 ). Notably, age, number of MAPCAs and DiGeorge syndrome did not achieve significance in our comparison. It is likely that the Alagille syndrome would be a risk factor for requiring unifocalization revision if there were more patients with this syndrome in the study.
DISCUSSION
This study was performed to analyse the risk factors associated with the need for unifocalization revision following midline unifocalization. Data demonstrate that patients who were unable to undergo a single-stage complete repair, patients with higher RV/Ao pressure ratios at completion of the initial repair and patients with absence of central pulmonary arteries were the 3 identifiable factors associated with the need for unifocalization revision. The results provide a first-time insight into the associated risks for unifocalization revision. It is also noteworthy that all 3 of these risk factors represent information that is known at the time of discharge from the hospital following the initial unifocalization.
These data suggest that specific cohorts of patients are at substantially higher risk for the need of subsequent unifocalization than their lower risk counterparts and, therefore, may deserve much more robust scrutiny during the follow-up period.
Eighty-five percent of the patients undergoing midline unifocalization were able to have a single-stage complete repair, and for these patients, the prevalence of requiring unifocalization revision was 14.7%. In contrast, patients who underwent a unifocalization/ shunt required unifocalization revision 37.8% of the time or approximately two and a half times more frequently. In our management algorithm, patients who have a unifocalization/shunt have failed the intraoperative pulmonary artery flow study, which is a tool designed to evaluate the resistance across the unifocalized bed prior to making a decision regarding VSD closure. Patients who fail this flow study have a predicted RV/Ao pressure ratio higher than 0.50 in the event that the VSD was closed [15] . It is evident that these patients have a higher resistance across the pulmonary vascular bed than patients who were able to undergo a single-stage complete repair. Thus, it is not surprising that the subgroup of patients who had a unifocalization/shunt had a higher prevalence of requiring subsequent unifocalization revision. Our previous analyses have demonstrated that patients who underwent an initial unifocalization/shunt also had a lower mid-term survival, lower chance to achieve eventual complete repair and higher RV/ Ao pressure ratios after a complete repair when compared with those who underwent a single-stage complete repair [7] .
Higher RV/Ao pressure ratio at the conclusion of the initial complete repair was the second factor that was associated with the subsequent need for unifocalization revision. The higher pressures provide physiological evidence that the resistance through the pulmonary vascular bed is more elevated. The aetiology of this increased resistance through the pulmonary bed could be multifactorial, including surgical narrowing in parts of the unifocalized bed, native stenoses in the native pulmonary artery tree or native stenoses in MAPCAs that were either not addressed or not amenable to repair during the surgical procedure. It is also conceivable that there may be portions of the pulmonary bed that have developed pulmonary vascular obstructive disease, particularly in patients who present late for surgery. While the difference in the RV/Ao pressure ratio between those who did require unifocalization revision and those who did not Figure 6 : (A) Bar graph demonstrating the prevalence of requiring unifocalization revision based on whether the patient initially had undergone a unifocalization/shunt compared with a single-stage complete repair (14.7% vs 37.8%, P < 0.001). (B) Bar graph demonstrating the RV/Ao pressure ratios at the conclusion of the complete repair for patients who subsequently required unifocalization revision (0.44 ± 0.08) and for those who did not require unifocalization revision (0.33 ± 0.07, P < 0.001). (C) Bar graph demonstrating the prevalence of requiring unifocalization revision based on whether the patient had absent central pulmonary arteries compared with patients who had central pulmonary arteries (32.8% vs 13.4%, P < 0.001). Ao: aorta; RV: right ventricle. Ao: aorta; MAPCAs: major aortopulmonary collateral arteries; RV: right ventricle.
was relatively modest (0.11), the inference is that patients on the higher end of the pressure ratio spectrum are at increased risk for requiring a subsequent unifocalization revision. The third factor that was associated with an increased need for unifocalization revision was the absence of central pulmonary arteries. While the first and second factors were both inter-related and predictable, the role of present or absent central pulmonary arteries in the subsequent need for unifocalization revision was not anticipated. This finding is somewhat surprising, given that our previous studies had demonstrated that the absence of central pulmonary arteries was not a risk factor at the time of the initial midline unifocalization [2] , and this has been corroborated by many other series as well [5, 6] . However, all of these data had focused on short-term measures of outcome (mortality, complete repair and RV/Ao pressure ratio), whereas this study is focused on an entirely different measure of outcome (i.e. the need for unifocalization revision). It is not entirely clear why absence of central pulmonary arteries does not manifest as a risk factor for midline unifocalization but does manifest in our analysis of unifocalization revisions. The majority of the patients with absent central pulmonary arteries have 2 or 3 large MAPCAs that provide abundant pulmonary blood flow and are relatively easy to unifocalize. However, it is also conceivable that there are subsets of patients with absent central pulmonary arteries that have less favourable anatomy (possibly a large number of diminutive MAPCAs), which could account for this becoming a risk factor for unifocalization revision.
In addition to identifying the 3 risk factors that were associated with the need for unifocalization revision, data also demonstrate numerous factors that were 'not' associated with an increased need for revision. Specifically, age, syndrome, unilateral versus bilateral MAPCA anatomy and the number of MAPCAs were not found to be associated risk factors. These findings are all consistent with our data regarding the risk factors at the time of midline unifocalization. However, the literature has had much debate regarding the role of these factors on outcomes following midline unifocalization [16, 17] . The differing results between centres are likely due to the result of multifactorial influences including surgical strategy and overall level of experience with this procedure.
Following discharge from the hospital after unifocalization, we recommend patients to undergo close scrutiny for any significant changes in their clinical status. We then recommend performing an assessment of the oxygen saturations and an echocardiographic examination on a quarterly basis. These studies are used for surveillance to detect any change in the relative amounts of pulmonary blood flow or any increase in the right ventricular pressures compared with the early pressure measurements. We also recommend pulmonary perfusion study every 6 months. This study is specifically used to detect an alteration in the distribution of blood flow. Finally, we recommend performing a cardiac catheterization at 1 year following surgery to visualize the reconstructed pulmonary artery bed. Any significant abnormality in non-invasive studies should prompt an earlier diagnostic catheterization and may also provide an opportunity to perform catheter-based interventions. Specifically, discrete stenoses of the central branch pulmonary arteries or unifocalized pulmonary arterial bed may be amenable to balloon dilation. In addition, conduit stenosis can be treated with balloon dilation or stenting to increase the longevity of the conduit. These catheter-based interventions provide a valuable adjunct to the surgical armamentarium. However, we would strongly discourage placement of stents in the central or peripheral branch pulmonary arteries, as stents inevitably develop neointimal fibrous tissue and become stenotic at the site of the stent.
The finding that there are specific risk factors associated with the need for subsequent unifocalization revision indicates that some subgroups of patients warrant even closer surveillance. Highrisk patients should likely undergo a foreshortened surveillance plan, including a lung perfusion study and cardiac catheterization within the first 3-6 months following discharge from the hospital. This may serve to identify these patients earlier and provide an opportunity to perform an entirely elective unifocalization revision. While we can state with reasonable certainty that 8 of the 13 interim and late deaths were not related specifically to changes in pulmonary vascularity, it is conceivable that several deaths could have been related to undetected and unaddressed problems of the unifocalized bed. Thus, it is also conceivable that several late deaths could have been avoided with more vigilant surveillance.
Patients who required unifocalization revision underwent this reoperation at a median of 12 months postoperatively compared with 31 months for patients who underwent reoperations that did not require unifocalization revision (Fig. 4) . This finding suggests that the changes in the pulmonary vascular bed that ultimately necessitate unifocalization revision occur relatively early. Interestingly, during these reoperations, it is our observation that we rarely can discern the 'cause of the problem', except when the anatomic issue is beyond the boundaries of the previous unifocalization. In this case, it is evident that the problem is native rather than surgical based. It is also our presumption that most patients who demonstrate a significant problem with the distal unifocalized bed are referred back to our group for further evaluation and treatment. In contrast, many patients (at least 20 to our knowledge) who do not manifest a problem with the unifocalized bed undergo conduit changes at their home institution. There have also been a small number of patients who have undergone a transcatheter Melody valve when the distal unifocalized bed has not required revision. For these reasons, there is certainly an inherent selection bias in those patients referred back to Stanford University for unifocalization revision versus conduit change.
CONCLUSION
In summary, this article summarizes our analysis of the risk factors for requiring unifocalization revision in patients undergoing an initial midline unifocalization. Data demonstrate 3 factors that were associated with the need for unifocalization revision: (i) failure to achieve a single-stage complete repair, (ii) higher RV/Ao pressure ratios at the conclusion of the initial unifocalization and (iii) absent central pulmonary arteries. All 3 of these factors are known information at the time of discharge from the hospital following the original unifocalization procedure and define a cohort of patients who are at increased risk for requiring a unifocalization revision. Having gleaned this information, it would be a reasonable policy to provide closer surveillance to this higher risk cohort. Whether this pre-emptive policy could impact outcomes in a positive manner is currently unknown and a matter of speculation.
